Register entry
- Registered sites
- 0
- Active NDC listings
- 5
- Live patents
- 29
- Exclusivities
- 1
- Countries
- 0
Catalogue
Drug listings by form and route
55 active NDC listings: 5 human prescription drug. By marketing category: NDA 5.
| Dosage form | NDCs |
|---|---|
| tablet, film coated | 5 |
| Route | NDCs |
|---|---|
| oral | 5 |
| Labeller name on the listing | NDCs |
|---|---|
| blueprint medicines corporation | 5 |
Exclusivity
Patents and exclusivities
29| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 11827642 | AYVAKITavapritinib | substance, product | Oct 2034 |
| 9200002 | AYVAKITavapritinib | substance, product | Oct 2034 |
| 9944651 | AYVAKITavapritinib | substance, product | Oct 2034 |
| 9994575 | AYVAKITavapritinib | substance, product | Oct 2034 |
| 11964980 | AYVAKITavapritinib | substance, product | Apr 2040 |
| 11999744 | AYVAKITavapritinib | use | Apr 2040 |
| 12252494 | AYVAKITavapritinib | use | Apr 2040 |
| 12060354 | AYVAKITavapritinib | use | Mar 2042 |
| Product | Exclusivity | Until |
|---|---|---|
| AYVAKITAVAPRITINIB | ODE-434 Orphan drug | May 2030 |
Catalogue
Marketed products
5| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Ayvakit | avapritinib | tablet, film coated, oral | 72064-110NDA |
| Ayvakit | avapritinib | tablet, film coated, oral | 72064-120NDA |
| Ayvakit | avapritinib | tablet, film coated, oral | 72064-125NDA |
| Ayvakit | avapritinib | tablet, film coated, oral | 72064-130NDA |
| Ayvakit | avapritinib | tablet, film coated, oral | 72064-150NDA |
Enquiry
Common questions
- Is Blueprint Medicines Corporation FDA approved?
- Blueprint Medicines Corporation holds no registered establishment of its own; 5 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Blueprint Medicines Corporation make?
- 5 products are listed under Blueprint Medicines Corporation in the openFDA NDC Directory, most often as tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.